Jad Daw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jad Daw has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Abdo Haddad
Hematology and Oncology, Cleveland Clinic Fairview Hospital, Cleveland, OH
2 shared publications- Hamed Daw
Hematology and Oncology, Cleveland Clinic Fairview Hospital, Cleveland, USA
2 shared publications - Sidra Khalid
Internal Medicine/Residency, Fairview Hospital/Cleveland Clinic, Cleveland, USA
2 shared publications - Abdo Haddad
Hematology and Oncology, Cleveland Clinic Fairview Hospital, Cleveland, USA
1 shared publication - Akshar Vipul Patel
Department of Orthopedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
1 shared publication - Ashoka Nautiyal
Department of Cardiology, Fairview Hospital, Cleveland Clinic, Cleveland, USA
1 shared publication
Latest Publications
- 21 July 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 196 (Pt B) , 110787
Automated detection of non-physiological artifacts on ECG signal: UK Biobank and CRIC
- 21 July 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 196 (Pt B) , 110787
Automated detection of non-physiological artifacts on ECG signal: UK Biobank and CRIC
- Open Access
- 11 May 2024
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 34 (3) , 693-697
Shoulder arthroplasty outcomes in a series of patients diagnosed with Parkinson’s disease: a retrospective analysis
- 11 May 2024
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 34 (3) , 693-697
Open AccessShoulder arthroplasty outcomes in a series of patients diagnosed with Parkinson’s disease: a retrospective analysis
- 1 July 2020
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 27 (4) , e406-e409
Imatinib-Associated Pneumocystis jirovecii Pneumonia in a Patient With Chronic Myeloid Leukemia
- 1 July 2020
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 27 (4) , e406-e409
Imatinib-Associated Pneumocystis jirovecii Pneumonia in a Patient With Chronic Myeloid Leukemia
- 1 July 2019
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 26 (4) , e533-e534
Delayed Hypersensitivity Reaction to Leucovorin
- 1 July 2019
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 26 (4) , e533-e534
Delayed Hypersensitivity Reaction to Leucovorin
- Open Access
- 22 July 2018
- Published by Springer Nature in Cureus
- Vol. 10 (7) , e3026
Primary Splenic Diffuse Large B-Cell Lymphoma: A Rare Case of Massive Splenomegaly and Thrombocytopenia
Primary splenic diffuse large B-cell lymphoma (DLBCL) is a rare type of non-Hodgkin’s lymphoma. It often presents with abdominal pain or splenomegaly. We present a case of a 68-year-old male who presented to the emergency department with left sided abdominal pain. Workup revealed massive splenomegaly and thrombocytopenia. A splenic biopsy confirmed the diagnosis of primary splenic DLBCL. The patient was treated with chemotherapy. This case highlights the importance of considering primary splenic DLBCL with splenomegaly and treating it with chemotherapy and/or splenectomy.
- 22 July 2018
- Published by Springer Nature in Cureus
- Vol. 10 (7) , e3026
Open AccessPrimary Splenic Diffuse Large B-Cell Lymphoma: A Rare Case of Massive Splenomegaly and Thrombocytopenia
Primary splenic diffuse large B-cell lymphoma (DLBCL) is a rare type of non-Hodgkin’s lymphoma. It often presents with abdominal pain or splenomegaly. We present a case of a 68-year-old male who presented to the emergency department with left sided abdominal pain. Workup revealed massive splenomegaly and thrombocytopenia. A splenic biopsy confirmed the diagnosis of primary splenic DLBCL. The patient was treated with chemotherapy. This case highlights the importance of considering primary splenic DLBCL with splenomegaly and treating it with chemotherapy and/or splenectomy.
- Open Access
- 14 March 2018
- Published by Springer Nature in Cureus
- Vol. 10 (3) , e2326
Fibromuscular Dysplasia Presenting as a Renal Infarct
Fibromuscular dysplasia (FMD) is a condition caused by an abnormal development or growth of cells in the arterial walls in the body. We present a case of a 49-year-old male who came in with a sudden onset of severe left-sided abdominal pain. Computed tomography (CT) scan of the abdomen was suggestive of a left renal infarct. He underwent renal angiography that showed FMD and a clot located in the anterior branch of the left renal artery. The patient was then treated with apixaban for the clot and amlodipine for the associated hypertension. Our case will highlight the importance of recognizing renal infarction as an initial presentation of FMD.
- 14 March 2018
- Published by Springer Nature in Cureus
- Vol. 10 (3) , e2326
Open AccessFibromuscular Dysplasia Presenting as a Renal Infarct
Fibromuscular dysplasia (FMD) is a condition caused by an abnormal development or growth of cells in the arterial walls in the body. We present a case of a 49-year-old male who came in with a sudden onset of severe left-sided abdominal pain. Computed tomography (CT) scan of the abdomen was suggestive of a left renal infarct. He underwent renal angiography that showed FMD and a clot located in the anterior branch of the left renal artery. The patient was then treated with apixaban for the clot and amlodipine for the associated hypertension. Our case will highlight the importance of recognizing renal infarction as an initial presentation of FMD.